Fujifilm to acquire Hitachi’s diagnostic imaging business for $1.64bn

By NS Healthcare Staff Writer

20 Dec 19

Fujifilm intends to further expand its medical systems business by integrating its advanced image processing and AI technologies

FacilitiesImaging, Diagnostics and AnalysisPatient Care

3M to sell its drug delivery business to Altaris for $650m

By NS Healthcare Staff Writer

13 Dec 19

3M will receive a total consideration of approximately $650m, including cash, an interest-bearing security, and a 17% non-controlling…

FacilitiesAsset Management

Sanofi to acquire clinical-stage biotechnology firm Synthorx for $2.5bn

By NS Healthcare Staff Writer

10 Dec 19

Synthorx’s immuno-oncology product candidate THOR-707 is expected to strengthen Sanofi’s immuno-oncology pipeline

FacilitiesAsset Management

Merck agrees to acquire ArQule in $2.7bn deal

By NS Healthcare Staff Writer

10 Dec 19

ArQule develops investigational candidate ARQ 531, an oral Bruton’s tyrosine kinase (BTK) inhibitor, for the treatment of B-cell…

FacilitiesAsset Management

Janssen to acquire rights to XBiotech’s bermekimab in $1.35bn deal

By NS Healthcare Staff Writer

09 Dec 19

Janssen has also signed a supply agreement with XBiotech to produce clinical supplies of bermekimab, using its advanced…

FacilitiesAsset Management

Astellas to acquire Audentes Therapeutics for $3bn

By NS Healthcare Staff Writer

04 Dec 19

The acquisition is expected to be completed in the first quarter of 2020, subject to customary closing conditions,…

FacilitiesAsset Management

Novartis to acquire The Medicines Company for $9.7bn

By NS Healthcare Staff Writer

25 Nov 19

The acquisition will enable Novartis to use the core commercial capabilities, including global cardiovascular field force of The…

FacilitiesAsset Management

Baring Private Equity Asia to acquire Lumenis for $1bn

By NS Healthcare Staff Writer

20 Nov 19

Lumenis has created solutions for previously untreatable conditions, and designed advanced technologies to transform existing treatment methods

FacilitiesAsset Management

Lupin to sell its stake in Japanese subsidiary Kyowa for $525m

By NS Healthcare Staff Writer

12 Nov 19

Kyowa develops, manufactures and sells branded and generic pharmaceutical products for patients in the Japanese market

FacilitiesAsset Management

UCB agrees to acquire Ra Pharmaceuticals for $2.5bn in cash

By NS Healthcare Staff Writer

11 Oct 19

Founded in 2008, Ra Pharma is engaged in developing therapeutics for the treatment of diseases caused by uncontrolled…

FacilitiesAsset Management